Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
AKR1C3
Name:
aldo-keto reductase family 1 member C3
Location:
10p15.1
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT00862134 | Randomized Multi-center Open-label Study of PR104 Versus PR104Docetaxel in Non-Small Cell Lung Cancer NSCLC | View | |
| NCT00862082 | Randomized Phase 12 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma HCC | View | |
| NCT03770325 | A Mechanistic Randomized Controlled Trial on the Cardiovascular Effect of Berberine | View | |
| NCT01037556 | PR104 in Treating Patients With RefractoryRelapsed Acute Leukemia | View | |
| NCT05811507 | Evaluation of Serum Adrenal Androgens Among Prepubertal and Pubertal Boys With Autism Spectrum Disorder | View | |
| NCT03176381 | Tissue Predictors of Abiraterone Benefit | View | |
| NCT04315324 | Study to Test AKR1C3-Activated Prodrug OBI-3424 OBI-3424 in Patients With RelapsedRefractory T-Cell Acute Lymphoblastic Leukemia T-ALL | View | |
| NCT06245330 | A Phase III Study of AST-001 in Subjects With Advanced Solid Tumors | View | |
| NCT06239155 | A Phase III Study of AST-3424 in Subjects With Advanced Solid Tumors | View | |
| NCT02347813 | Preventing Squamous Cell Skin Cancer | View |